Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sayoko Kajiume"'
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 42(5)
Recently, novel therapeutic regimens, such as FOLFIRINOX, have been demonstrated to show promising anti-cancer activity and to be superior to single-agent gemcitabine for unresectable pancreatic cancer patients with good performance status. In this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d0af81a6c074ec01c0dc10e170dbdd02
https://pubmed.ncbi.nlm.nih.gov/25981661
https://pubmed.ncbi.nlm.nih.gov/25981661
Autor:
Satoshi, Nagashima, Takayoshi, Kiba, Yoshikazu, Ogawa, Takuya, Mura, Sayoko, Kajiume, Yuuko, Okada, Nao, Morii, Hirotoshi, Takahashi, Yasunori, Ichiba, Hiroyasu, Yamashiro
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 42(5)
Here, we report about a 60-year-old woman with metastatic breast cancer who was successfully treated for paclitaxelinduced peripheral neuropathy with duloxetine. She was administered trastuzumab plus paclitaxel(PTX)combination therapy that was ultima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8dfd48a2cbd17dd7f199ffaaafd2f4b
https://pubmed.ncbi.nlm.nih.gov/25981658
https://pubmed.ncbi.nlm.nih.gov/25981658
Autor:
Keita, Kameda, Takayoshi, Kiba, Yoshikazu, Ogawa, Shizue, Kimoto, Sayoko, Kajiume, Yuuko, Okada, Nao, Morii, Hirotoshi, Takahashi, Yasunori, Ichiba, Hiroyasu, Yamashiro
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 41(10)
Epirubicin hydrochloride injection is indicated as a therapy for patients with primary breast cancer. This drug has been reclassified as a drug with high emetic potential according to the American Society of Clinical Oncology Guidelines for Antiemeti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::61cc65e2160c8f9eec76f30caf2bcffb
https://pubmed.ncbi.nlm.nih.gov/25335710
https://pubmed.ncbi.nlm.nih.gov/25335710
Autor:
Yoshikazu, Ogawa, Takayoshi, Kiba, Kikuo, Nakano, Keiichi, Fujiwara, Hitoshi, Taniguchi, Atsuko, Hosokawa, Toshihisa, Nakashima, Shizue, Kimoto, Sayoko, Kajiume, Yuuko, Okada, Yasunori, Ichiba
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 41(4)
Gefitinib anderlotinib, which are epidermal growth factor receptor(EGFR)tyrosine kinase inhibitors(TKIs), have been usedfor the treatment of inoperable andrecurrent non-small cell lung cancer(NSCLC)patients. These drugs are known to cause a skin rash
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::43f3cdd471e8c2ffed108f5900e48692
https://pubmed.ncbi.nlm.nih.gov/24743373
https://pubmed.ncbi.nlm.nih.gov/24743373
Publikováno v:
Clinical journal of oncology nursing. 17(5)
Agents used in cancer treatment can cause many side effects in patients. Oxaliplatin is a platinum-based cytotoxic agent that is used in the treatment of colorectal cancers, and one of its potential side effects is vascular pain. The current article
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4343d37b995bb932309651bd4c481fdf
https://pubmed.ncbi.nlm.nih.gov/24080056
https://pubmed.ncbi.nlm.nih.gov/24080056
Publikováno v:
Annals of Oncology. 26:vii120
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::380c4b0e69492bf95fa6adf1bd628a35
https://doi.org/10.1093/annonc/mdv472.68
https://doi.org/10.1093/annonc/mdv472.68